La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Dr. Sulaiman Al Habib Medical Services Group Performance dei guadagni passati
Il passato criteri di controllo 3/6
Dr. Sulaiman Al Habib Medical Services Group ha registrato una crescita degli utili a un tasso medio annuo di 20.5%, mentre il settore Healthcare ha registrato utili in crescita a un tasso medio annuo di 18.7%. I ricavi sono stati in crescita a un tasso medio annuo di 15.7%. Il ritorno sul capitale proprio di Dr. Sulaiman Al Habib Medical Services Group è 31.4% e ha margini netti di 21.7%.
Informazioni chiave
20.5%
Tasso di crescita degli utili
20.5%
Tasso di crescita dell'EPS
Healthcare Crescita del settore | 12.3% |
Tasso di crescita dei ricavi | 15.7% |
Rendimento del capitale proprio | 31.4% |
Margine netto | 21.7% |
Ultimo aggiornamento sui guadagni | 30 Jun 2024 |
Aggiornamenti sulle prestazioni recenti
Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Recent updates
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Feb 20Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings
Jan 09We Like These Underlying Return On Capital Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 28We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 02Here's Why Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has Caught The Eye Of Investors
Sep 21Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Aug 10Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Well Worth Watching
Jun 17Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Returns At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Are On The Way Up
May 06Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Mar 13Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital Are Heading Higher
Jan 30With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Dec 07Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Oct 23If EPS Growth Is Important To You, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Presents An Opportunity
Sep 08Estimating The Intrinsic Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Aug 24Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching
Aug 08Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward
Jul 12Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?
May 31A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
May 17Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Will Pay A Larger Dividend Than Last Year At ر.س0.83
Apr 28Should You Think About Buying Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Now?
Apr 09Return Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Appealing
Mar 06Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is An Interesting Stock
Feb 16Returns On Capital At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Have Stalled
Dec 05Do Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings Warrant Your Attention?
Nov 17Investors Could Be Concerned With Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Aug 30Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Aug 01Estimating The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Jun 11Capital Allocation Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Ideal
May 27Earnings Beat: Dr. Sulaiman Al Habib Medical Services Group Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 27Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Apr 06A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Feb 04Is Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Shareholder Ownership Skewed Towards Insiders?
Jan 14Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Is Yielding 1.5% - But Is It A Buy?
Dec 23Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 27Ripartizione dei ricavi e delle spese
Come Dr. Sulaiman Al Habib Medical Services Group guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storia dei guadagni e delle entrate
Data | Ricavi | Guadagni | Spese G+A | Spese di R&S |
---|---|---|---|---|
30 Jun 24 | 10,024 | 2,176 | 1,257 | 0 |
31 Mar 24 | 9,723 | 2,108 | 1,206 | 0 |
31 Dec 23 | 9,508 | 2,046 | 1,158 | 0 |
30 Sep 23 | 9,276 | 1,962 | 1,134 | 0 |
30 Jun 23 | 8,885 | 1,838 | 1,089 | 0 |
31 Mar 23 | 8,627 | 1,750 | 1,069 | 0 |
31 Dec 22 | 8,311 | 1,651 | 1,032 | 0 |
30 Sep 22 | 8,025 | 1,593 | 971 | 0 |
30 Jun 22 | 7,809 | 1,521 | 932 | 0 |
31 Mar 22 | 7,547 | 1,448 | 887 | 0 |
31 Dec 21 | 7,250 | 1,377 | 850 | 0 |
30 Sep 21 | 6,974 | 1,311 | 822 | 0 |
30 Jun 21 | 6,761 | 1,261 | 851 | 0 |
31 Mar 21 | 6,213 | 1,128 | 796 | 0 |
31 Dec 20 | 5,862 | 1,055 | 738 | 0 |
30 Sep 20 | 5,575 | 1,008 | 696 | 0 |
30 Jun 20 | 5,178 | 907 | 618 | 0 |
31 Mar 20 | 5,132 | 883 | 632 | 0 |
31 Dec 19 | 5,016 | 870 | 647 | 0 |
30 Sep 19 | 4,816 | 825 | 619 | 0 |
30 Jun 19 | 4,735 | 835 | 601 | 0 |
31 Mar 19 | 4,646 | 819 | 569 | 0 |
31 Dec 18 | 4,588 | 801 | 551 | 0 |
31 Dec 17 | 4,687 | 658 | 904 | 0 |
31 Dec 16 | 4,868 | 1,010 | 959 | 0 |
31 Dec 15 | 5,123 | 1,329 | 859 | 0 |
Guadagni di qualità: 4013 ha un livello elevato di guadagni non monetari.
Margine di profitto in crescita: Gli attuali margini di profitto netti di 4013 (21.7%) 4013 sono più alti rispetto allo scorso anno (20.7%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: Gli utili di 4013 sono cresciuti in modo significativo del 20.5% all'anno negli ultimi 5 anni.
Accelerare la crescita: La crescita degli utili di 4013 nell'ultimo anno ( 18.4% ) è inferiore alla media quinquennale ( 20.5% all'anno).
Guadagni vs Settore: La crescita degli utili 4013 nell'ultimo anno ( 18.4% ) non ha superato quella del settore Healthcare 42.3%.
Rendimento del capitale proprio
ROE elevato: Il Return on Equity ( 31.4% ) di 4013 è considerato alto.